A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Obinutuzumab Compared to Chlorambucil in Combination with Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Type of Cancer
Leukemia

Site
East Brunswick

Sponsor
Gilead

Protocol Number
GS-312-0118

To Learn More Call
201-510-0910